Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5230 Centre Ave
Dept of Radiation Oncology
Pittsburgh, PA 15232Phone+1 412-623-6720Fax+1 412-623-2409
Education & Training
- University of Pennsylvania Health SystemResidency, Radiation Oncology, 2000 - 2004
- Albert Einstein Medical CenterInternship, Transitional Year, 1999 - 2000
- Lewis Katz School of Medicine at Temple UniversityClass of 1999
Certifications & Licensure
- PA State Medical License 2000 - 2024
- WV State Medical License 2006 - 2009
- OH State Medical License 2006 - 2008
- American Board of Radiology Radiation Oncology
Clinical Trials
- Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
- Hypofractionated SBRT For Prostate Cancer Start of enrollment: 2010 Oct 07
- Measuring the Effect of Radiation Therapy on Patient Activity Levels Start of enrollment: 2015 Jul 01
Publications & Presentations
PubMed
- 107 citationsInduction Docetaxel, Cisplatin, and Cetuximab Followed by Concurrent Radiotherapy, Cisplatin, and Cetuximab and Maintenance Cetuximab in Patients With Locally Advanced...Athanassios Argiris, Dwight E. Heron, Ryan P. Smith, Seungwon Kim, Michael K. Gibson
Journal of Clinical Oncology. 2010-12-20 - 33 citationsManagement of patients treated with chemoradiotherapy for head and neck cancer without prophylactic feeding tubes: The University of Pittsburgh experienceB. T. McLaughlin, Abhay S. Gokhale, Yongli Shuai, Joyce Diacopoulos, Ricardo L. Carrau
The Laryngoscope. 2009-10-29 - 36 citationsPhase II Study of Induction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic ...George Van Buren, Ramesh K. Ramanathan, Alyssa M. Krasinskas, Ryan P. Smith, Gerard Abood
Annals of Surgical Oncology. 2013-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: